Get insights on Biogen’s Leqembi sales outlook, clinical value, risks, and what new drug approvals may mean for investors.

Saturday Night Live took a jab at the president's health with a new insult that attacks his weight and cognitive state, as rumors of Donald Trump's health continue to swirl.

In the midst of regulatory and political upheaval, biopharma’s R&D engine kept running, churning out highs and lows in equal ...